HomeCompareJNNDF vs JNJ

JNNDF vs JNJ: Dividend Comparison 2026

JNNDF yields 497.51% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNNDF wins by $59077.77M in total portfolio value
10 years
JNNDF
JNNDF
● Live price
497.51%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$59077.80M
Annual income
$42,337,618,926.15
Full JNNDF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — JNNDF vs JNJ

📍 JNNDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJNNDFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JNNDF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JNNDF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JNNDF
Annual income on $10K today (after 15% tax)
$42,288.56/yr
After 10yr DRIP, annual income (after tax)
$35,986,976,087.23/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNNDF beats the other by $35,986,972,101.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JNNDF + JNJ for your $10,000?

JNNDF: 50%JNJ: 50%
100% JNJ50/50100% JNNDF
Portfolio after 10yr
$29538.92M
Annual income
$21,168,811,807.77/yr
Blended yield
71.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JNNDF
No analyst data
Altman Z
-0.3
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JNNDF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJNNDFJNJ
Forward yield497.51%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$59077.80M$30.3K
Annual income after 10y$42,337,618,926.15$4,689.40
Total dividends collected$57621.01M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JNNDF vs JNJ ($10,000, DRIP)

YearJNNDF PortfolioJNNDF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$60,451$49,751.24$10,592$272.30+$49.9KJNNDF
2$345,760$281,077.06$11,289$357.73+$334.5KJNNDF
3$1,872,451$1,502,487.97$12,123$472.89+$1.86MJNNDF
4$9,607,890$7,604,367.26$13,141$629.86+$9.59MJNNDF
5$46,747,174$36,466,732.29$14,408$846.81+$46.73MJNNDF
6$215,840,817$165,821,339.91$16,021$1,151.60+$215.82MJNNDF
7$946,491,215$715,541,540.86$18,122$1,588.22+$946.47MJNNDF
8$3,945,219,030$2,932,473,430.79$20,930$2,228.20+$3945.20MJNNDF
9$15,645,033,095$11,423,648,732.35$24,792$3,191.91+$15645.01MJNNDF
10$59,077,804,338$42,337,618,926.15$30,274$4,689.40+$59077.77MJNNDF

JNNDF vs JNJ: Complete Analysis 2026

JNNDFStock

Japan Display Inc. designs, develops, produces, and sells small-and medium-sized display devices and related products in Japan and internationally. The company offers various LCD modules for mobile applications, such as smartphone, tablet, and notebook PC devices; wearable applications, including sports watches, healthcare equipment, and action cameras; automotive applications, such as car navigation, instrument panel, and rear seat monitor; devices used for display and diagnosis in medical field comprising mammography, PACS, surgical monitor, ultrasonography, X-ray sensitivity sensor, etc.; IoT products and applications, including outdoor sports gears, medical and healthcare devices, remote controllers, and portable devices; and industrial applications. It also provides landscape IPS LCD modules for single-lens reflex and high-end compact digital cameras. The company was incorporated in 2002 and is headquartered in Tokyo, Japan.

Full JNNDF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this JNNDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JNNDF vs SCHDJNNDF vs JEPIJNNDF vs OJNNDF vs KOJNNDF vs MAINJNNDF vs ABBVJNNDF vs MRKJNNDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.